CURE’s immunotherapy page features the latest cancer news and updates on immunotherapy Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in immunotherapy.
August 14th 2023
Certain patients with penile squamous cell carcinoma responded to therapy with an immune checkpoint inhibitor, according to recent research.
Guidelines Equip Patients to Understand Immunotherapy Side Effects
February 20th 2018To help educate patients and enable health care teams to effectively manage these side effects, the National Comprehensive Cancer Network (NCCN) and the American Society of Clinical Oncology (ASCO) issued new guidelines on understanding and managing immunotherapy-related toxicities.
Efficacy Offsets High Costs for Immunotherapy in US, But Not Overseas
February 14th 2018Researchers from Israel, the United Kingdom (UK) and Canada sought to determine the cost-effectiveness of Keytruda for the second-line treatment of patients with advanced bladder cancer. Drug costs were compared between the US, UK, Canada and Australia.
Adding Tecentriq to Chemo Regimen Improves Lung Cancer Outcomes
January 31st 2018Not all patients with non-small cell lung cancer (NSCLC) respond to immunotherapy, so researchers are exploring the use of combination regimens, including immune checkpoint inhibitors and chemotherapy, to improve outcomes in these patients.
Combinations May Be the Future of Immunotherapy in Ovarian Cancer
January 10th 2018To date, trials testing the use of immunotherapy in the treatment of ovarian cancer yielded disappointing results. However, researchers are not giving up. Instead, they’re investigating to see if immunotherapy drugs – such as PD1 and PDL-1 inhibitors – can be combined with other agents to benefit patients.
Will Immunotherapy and Radiation Be Combined in Lung Cancer Treatment?
December 27th 2017Checkpoint inhibitors continue to show promise in the treatment of patients with non-small cell lung cancer (NSCLC), but researchers are now exploring the efficacy of these agents when combined with radiation therapy (RT).